TMEFF2


Summary: This gene encodes a member of the tomoregulin family of transmembrane proteins. This protein has been shown to function as both an oncogene and a tumor suppressor depending on the cellular context and may regulate prostate cancer cell invasion. Multiple soluble forms of this protein have been identified that arise from both an alternative splice variant and ectodomain shedding. Additionally, this gene has been found to be hypermethylated in multiple cancer types. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Feb 2015].

Loading, please wait...
Name
OMIM ID
Ensembl ID
HGNC ID
PHARMGKB ID
Map Location

Gene Categories:

DRUGGABLE GENOME

GO terms in TMEFF2


Loading, please wait...
Term Type
Evidence Type
GO Term ID
GO Des.
BP IDA GO:0030336 negative regulation of cell migration
BP IDA GO:0044319 wound healing, spreading of cells
BP IMP GO:0045720 negative regulation of integrin biosynthetic process
BP IDA GO:0051497 negative regulation of stress fiber assembly
CC IEA GO:0005576 extracellular region
CC NAS GO:0016021 integral component of membrane
Showing 1 to 6 of 7 rows

Gene expression in normal tissue: TMEFF2

Gene-model tissue-cancer distribution: Bubble Plot

Gene-drug pathway distribution

Pathways in TMEFF2


Loading, please wait...
Database
Pathway ID
Pathway Des.
pid myc_represspathway Validated targets of C-MYC transcriptional repression
Showing 1 to 1 of 1 rows

Gene-Drug: Aster Plot


Loading, please wait...
Drug ID
Drug Name
Model Num.
iGMDRD133 Lapatinib 1
Showing 1 to 1 of 1 rows

Gene in drug-gene network: Network Plot

Gene-drug targets distribution

Gene Structure: PDB

Models in TMEFF2

Loading, please wait...
Model
Level
Reference ID
Tissue
Cancer
Drug
Clinical Response
Source
No matching records found

​​​​